John Malaty

1000 total citations · 1 hit paper
33 papers, 687 citations indexed

About

John Malaty is a scholar working on Surgery, Otorhinolaryngology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Malaty has authored 33 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Otorhinolaryngology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Malaty's work include Ear Surgery and Otitis Media (5 papers), Innovations in Medical Education (4 papers) and Medicinal Plant Extracts Effects (4 papers). John Malaty is often cited by papers focused on Ear Surgery and Otitis Media (5 papers), Innovations in Medical Education (4 papers) and Medicinal Plant Extracts Effects (4 papers). John Malaty collaborates with scholars based in United States, Canada and France. John Malaty's co-authors include Irene A. Malaty, Steven N. Hochwald, Edward M. Copeland, Lyle L. Moldawer, D. Scott Lind, Sally L. D. MacKay, Girish Mishra, George Samraj, K. Huber and Danielle Poulton and has published in prestigious journals such as Diabetes Care, International Journal of Molecular Sciences and The Laryngoscope.

In The Last Decade

John Malaty

28 papers receiving 668 citations

Hit Papers

Advanced Liver Fibrosis Is Common in Patients With Type 2... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Malaty United States 8 223 185 129 120 109 33 687
Tilo Wuensch Germany 13 86 0.4× 163 0.9× 101 0.8× 50 0.4× 157 1.4× 18 591
Eva Juárez-Hernández Mexico 11 238 1.1× 116 0.6× 38 0.3× 90 0.8× 72 0.7× 42 594
Füsun F. Bölükbaş Türkiye 12 190 0.9× 84 0.5× 39 0.3× 46 0.4× 171 1.6× 21 570
Weihong Sha China 17 102 0.5× 345 1.9× 133 1.0× 37 0.3× 161 1.5× 65 1.0k
Takeshi Mizukami Japan 17 267 1.2× 186 1.0× 71 0.6× 108 0.9× 250 2.3× 59 855
S. D. Lee Taiwan 13 191 0.9× 133 0.7× 32 0.2× 53 0.4× 216 2.0× 28 810
Eckart G. Hahn Germany 17 132 0.6× 113 0.6× 54 0.4× 243 2.0× 409 3.8× 51 987
Marek Waluga Poland 14 334 1.5× 103 0.6× 38 0.3× 61 0.5× 165 1.5× 53 653
Aimee L. Anderson United States 14 241 1.1× 224 1.2× 58 0.4× 38 0.3× 238 2.2× 23 942
Zhigang Chang China 16 90 0.4× 365 2.0× 104 0.8× 31 0.3× 61 0.6× 37 752

Countries citing papers authored by John Malaty

Since Specialization
Citations

This map shows the geographic impact of John Malaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Malaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Malaty more than expected).

Fields of papers citing papers by John Malaty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Malaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Malaty. The network helps show where John Malaty may publish in the future.

Co-authorship network of co-authors of John Malaty

This figure shows the co-authorship network connecting the top 25 collaborators of John Malaty. A scholar is included among the top collaborators of John Malaty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Malaty. John Malaty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Chengguo, John Malaty, Frank A. Orlando, et al.. (2024). The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial. BMC Complementary Medicine and Therapies. 24(1). 422–422.
2.
Culmer, Nathan, et al.. (2024). Pursuing Scholarship: Creating Effective Conference Submissions. PRiMER. 8. 13–13. 1 indexed citations
3.
Hu, Qi, Zhixin Tang, Allison M. Lynch, et al.. (2024). One-Week Kava Dietary Supplementation Increases Both Urinary N- and O-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers. Chemical Research in Toxicology. 37(9). 1515–1523.
4.
Eddy, Elizabeth M., et al.. (2023). Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients. Clinical and Translational Science. 17(1). e13692–e13692. 6 indexed citations
5.
Malaty, John, et al.. (2023). Incidental seromucinous hamartoma of the anterior nasal cavity presenting after episode of vestibular neuritis. BMJ Case Reports. 16(11). e254889–e254889.
6.
Bian, Tengfei, K. Ballas, Allison M. Lynch, et al.. (2023). Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences. 24(11). 9539–9539. 7 indexed citations
7.
Xing, Chengguo, et al.. (2023). Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava. Trials. 24(1). 36–36. 1 indexed citations
8.
Carek, Stephen M., et al.. (2023). Advanced Practice Providers in Departments of Family Medicine: Status, Supervision, and Services. The Journal of the American Board of Family Medicine. 36(6). 1058–1061. 2 indexed citations
9.
LeLaurin, Jennifer H., James F. Thrasher, Scott M. Strayer, et al.. (2022). Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes. Preventive Medicine Reports. 26. 101745–101745. 2 indexed citations
10.
Malaty, John, et al.. (2021). Dysosmia and drug tolerance with use of venlafaxine. BMJ Case Reports. 14(4). e240547–e240547. 3 indexed citations
11.
Lomonaco, Romina, Eddison Godinez Leiva, Fernando Bril, et al.. (2020). Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes Care. 44(2). 399–406. 231 indexed citations breakdown →
12.
Malaty, John, et al.. (2020). Impact of Providing Data on Family Medicine Practice Management Education. Family Medicine. 52(6). 432–434.
13.
Dietrich, Eric, et al.. (2019). Comparison of Factors Identified by Patients and Physicians Associated with Hospital Readmission (COMPARE2). Southern Medical Journal. 112(4). 244–250. 4 indexed citations
14.
Loftus, Tyler J., David J. Hall, John Malaty, et al.. (2019). Associations Between National Board Exam Performance and Residency Program Emphasis on Patient Safety and Interprofessional Teamwork. Academic Psychiatry. 43(6). 581–584. 1 indexed citations
15.
Malaty, John, et al.. (2017). Seeking Quality and Attracting Candidates: Residency Program Directors’ Perceptions. 1 indexed citations
16.
Malaty, John, Ara Jo, Rebecca Tanner, et al.. (2017). Hearing Impairment and Undiagnosed Disease: The Potential Role of Clinical Recommendations. Journal of Speech Language and Hearing Research. 60(1). 231–237. 3 indexed citations
17.
Malaty, John, et al.. (2015). Thyrotoxicosis: an under-recognised aetiology. BMJ Case Reports. 2015. bcr2014208119–bcr2014208119. 6 indexed citations
18.
Malaty, John & Irene A. Malaty. (2014). Hypertensive urgency: an important aetiology of rebound hypertension. BMJ Case Reports. 2014. bcr2014206022–bcr2014206022. 4 indexed citations
19.
Malaty, John, James Lee, Mei Zhang, Gary Stevens, & Patrick J. Antonelli. (2005). Hearing loss and extent of labyrinthine injury in Pseudomonas otitis media. Otolaryngology. 132(1). 25–29. 2 indexed citations
20.
Lind, D. Scott, Steven N. Hochwald, John Malaty, et al.. (2001). Nuclear factor-κB is upregulated in colorectal cancer. Surgery. 130(2). 363–369. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026